Holly Y. Lee
80 St. George St, M5S 3H6
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Plasma cell identity escape drives resistance to anti-BCMA T-cell-redirecting therapy in multiple myeloma.
Journal: bioRxiv : the preprint server for biology
Published: December 19, 2025
Multimodal antigenic escape to GPRC5D-targeted T cell engagers in multiple myeloma.
Journal: Nature medicine
Published: June 23, 2025
B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape.
Journal: Journal of hematology & oncology
Published: June 03, 2025
Timing Genomic Antigen Loss in Multiple Myeloma Treated with T Cell-Redirecting Immunotherapies.
Journal: Blood cancer discovery
Published: January 07, 2025
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myeloma.
Journal: Blood
Published: December 16, 2024
Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review.
Journal: Current oncology (Toronto, Ont.)
Published: October 31, 2024
Clinical and Pathological Characteristics of Non-AL Amyloidosis MGRS: A Single-Center Experience Over 10 Years.
Journal: Canadian journal of kidney health and disease
Published: August 21, 2024
Last Updated: 09/26/2026